Zobrazeno 1 - 10
of 128
pro vyhledávání: '"F. Claudiani"'
Autor:
P. Bellotti, R. Lionetto, Raffaele Griffo, Gianfranco Mazzotta, Vecchio C, G. Scopinaro, F. Claudiani, A. Camerini
Publikováno v:
European Heart Journal. 13:330-337
In 183 consecutive patients with recent, uncomplicated myocardial infarction, the following variables were associated with 4-year cardiac death: haemodynamic decompensation with exercise (P = 0.01), left ventricular ejection fraction at rest (P = 0.0
Publikováno v:
The Italian Journal of Neurological Sciences. 11:43-47
86 patients suffering from various senile and presenile degenerative diseases were studied using scinticisternography with In111-DTPA. Flow reversal and delayed clearance were observed in 62 of these patients. These alterations, possibly related to t
Autor:
F. Chiarella, P. Strada, Lupi G, F. Claudiani, G. Scopinaro, S. Domenicucci, Paolo Bellotti, G. Mazzotta, C Vecchio
Publikováno v:
Cardiology. 77:272-279
This study was designed to evaluate whether indobufen and ticlopidine can induce changes in the size of left ventricular thrombi and variations in the deposition of platelets on thrombus surface. Forty-seven patients with left ventricular thrombosis,
Publikováno v:
Cancer. 76:1662-1664
Background 131-I-metaiodobenzylguanidine is a radioiodinated compound selectively concentrated by cells of neuroectodermal origin, including neuroblastoma cells, for this reason it may represent a promising treatment modality for neuroblastoma in chi
Autor:
A, Garaventa, C, Pianca, M, Conte, M, Nigro, B, De Bernardi, F, Claudiani, P, Stimamiglio, L, Bertolazzi, M, Cabria, G P, Villavecchia
Publikováno v:
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 39(4 Suppl 1)
The aim of this paper is to focus on our previous experience with the treatment of Group 3 and 4 neuroblastoma patients and on the therapeutic use of [131I]MIBG, to better define the role of this radioactive drug in the treatment of neuroblastoma (NB
Autor:
F, Claudiani, P, Stimamiglio, L, Bertolazzi, M, Cabria, M, Conte, G P, Villavecchia, A, Garaventa, E, Lanino, B, De Bernardi, G, Scopinaro
Publikováno v:
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 39(4 Suppl 1)
In a group of 97 patients aged from 6 months to 12 years, all with suspected or proven neural crest tumours, metaiodobenzylguanidine (MIBG) scintigraphy was performed at the time of diagnosis and, in some instances, after induction chemotherapy. All
Publikováno v:
Cancer. 76(9)
131-I-metaiodobenzylguanidine is a radioiodinated compound selectively concentrated by cells of neuroectodermal origin, including neuroblastoma cells, for this reason it may represent a promising treatment modality for neuroblastoma in childhood. Alt
Publikováno v:
La Radiologia medica. 86(3)
Publikováno v:
Journal of nuclear biology and medicine (Turin, Italy : 1991). 37(1)
Cerebral SPECT with 99mTc-HM-PAO allows a semiquantitative evaluation of regional cerebral blood flow (rCBF). Using this method we studied 25 patients affected by slight-to-moderate degree hypertension, in effective pharmacological treatment, and a c
Autor:
F, Claudiani, A, Garaventa, L, Bertolazzi, G P, Villavecchia, M, Cabria, G, Scopinaro, M, Bestagno, P, Guerra, N, Canevarollo, G, Scielzo
Publikováno v:
Journal of nuclear biology and medicine (Turin, Italy : 1991). 35(4)
Forty-two children with advanced neuroblastoma who either failed with first-line therapy or relapsed after achieving a complete remission, were considered for treatment with [131I]metaiodobenzylguanidine (131I-MIBG). We subdivided 42 cases into 5 gro